.Pharmacolibrary.Drugs.C_CardiovascularSystem.C05B_AntivaricoseTherapy.C05BB03_InvertSugar.InvertSugar .Pharmacolibrary.Drugs.C_CardiovascularSystem.C05B_AntivaricoseTherapy.C05BB03_InvertSugar.InvertSugar| name: | InvertSugar | |
| ATC code: | C05BB03 | route: |
| compartments: | 0 | |
| dosage: | 1 | mg |
| volume of distribution: | 1 | L |
| clearance: | 0 | |
| other parameters in model implementation | ||
Invert sugar is a mixture of glucose and fructose produced by the hydrolysis of sucrose. It has been used historically as a plasma volume expander and as a source of carbohydrate calories in parenteral nutrition, particularly when glucose administration is undesirable (e.g., hereditary fructose intolerance). It is not a commonly approved drug for clinical use today.
No pharmacokinetic parameters for invert sugar (ATC code C05BB03) could be found in published literature for administration as a medicinal product in humans.